Taiwan · Delayed Price · Currency is TWD Concord Medical Statistics
Total Valuation
Concord Medical has a market cap or net worth of TWD 866.67 million. The enterprise value is 797.03 million.
| Market Cap | 866.67M |
| Enterprise Value | 797.03M |
Important Dates
The next estimated earnings date is Friday, March 6, 2026.
| Earnings Date | Mar 6, 2026 |
| Ex-Dividend Date | Apr 10, 2025 |
Share Statistics
Concord Medical has 33.33 million shares outstanding. The number of shares has increased by 0.06% in one year.
| Current Share Class | 33.33M |
| Shares Outstanding | 33.33M |
| Shares Change (YoY) | +0.06% |
| Shares Change (QoQ) | -0.23% |
| Owned by Insiders (%) | 5.67% |
| Owned by Institutions (%) | n/a |
| Float | 10.34M |
Valuation Ratios
The trailing PE ratio is 15.86.
| PE Ratio | 15.86 |
| Forward PE | n/a |
| PS Ratio | 0.96 |
| PB Ratio | 1.26 |
| P/TBV Ratio | 1.26 |
| P/FCF Ratio | 7.68 |
| P/OCF Ratio | 4.64 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 5.21, with an EV/FCF ratio of 7.06.
| EV / Earnings | 14.56 |
| EV / Sales | 0.88 |
| EV / EBITDA | 5.21 |
| EV / EBIT | 11.77 |
| EV / FCF | 7.06 |
Financial Position
The company has a current ratio of 1.84, with a Debt / Equity ratio of 0.34.
| Current Ratio | 1.84 |
| Quick Ratio | 1.80 |
| Debt / Equity | 0.34 |
| Debt / EBITDA | 1.53 |
| Debt / FCF | 2.08 |
| Interest Coverage | 19.36 |
Financial Efficiency
Return on equity (ROE) is 8.03% and return on invested capital (ROIC) is 8.65%.
| Return on Equity (ROE) | 8.03% |
| Return on Assets (ROA) | 3.63% |
| Return on Invested Capital (ROIC) | 8.65% |
| Return on Capital Employed (ROCE) | 7.86% |
| Weighted Average Cost of Capital (WACC) | 5.09% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.78 |
| Inventory Turnover | 200.54 |
Taxes
In the past 12 months, Concord Medical has paid 14.41 million in taxes.
| Income Tax | 14.41M |
| Effective Tax Rate | 20.85% |
Stock Price Statistics
The stock price has decreased by -0.19% in the last 52 weeks. The beta is 0.34, so Concord Medical's price volatility has been lower than the market average.
| Beta (5Y) | 0.34 |
| 52-Week Price Change | -0.19% |
| 50-Day Moving Average | 26.25 |
| 200-Day Moving Average | 26.23 |
| Relative Strength Index (RSI) | 47.42 |
| Average Volume (20 Days) | 11,458 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Concord Medical had revenue of TWD 905.31 million and earned 54.73 million in profits. Earnings per share was 1.64.
| Revenue | 905.31M |
| Gross Profit | 117.29M |
| Operating Income | 67.72M |
| Pretax Income | 69.10M |
| Net Income | 54.73M |
| EBITDA | 150.77M |
| EBIT | 67.72M |
| Earnings Per Share (EPS) | 1.64 |
Balance Sheet
The company has 305.65 million in cash and 234.41 million in debt, with a net cash position of 71.24 million or 2.14 per share.
| Cash & Cash Equivalents | 305.65M |
| Total Debt | 234.41M |
| Net Cash | 71.24M |
| Net Cash Per Share | 2.14 |
| Equity (Book Value) | 690.55M |
| Book Value Per Share | 20.67 |
| Working Capital | 274.69M |
Cash Flow
In the last 12 months, operating cash flow was 186.69 million and capital expenditures -73.88 million, giving a free cash flow of 112.81 million.
| Operating Cash Flow | 186.69M |
| Capital Expenditures | -73.88M |
| Free Cash Flow | 112.81M |
| FCF Per Share | 3.38 |
Margins
Gross margin is 12.96%, with operating and profit margins of 7.48% and 6.05%.
| Gross Margin | 12.96% |
| Operating Margin | 7.48% |
| Pretax Margin | 7.63% |
| Profit Margin | 6.05% |
| EBITDA Margin | 16.65% |
| EBIT Margin | 7.48% |
| FCF Margin | 12.46% |
Dividends & Yields
This stock pays an annual dividend of 1.10, which amounts to a dividend yield of 4.23%.
| Dividend Per Share | 1.10 |
| Dividend Yield | 4.23% |
| Dividend Growth (YoY) | 10.00% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 66.99% |
| Buyback Yield | -0.06% |
| Shareholder Yield | 4.17% |
| Earnings Yield | 6.32% |
| FCF Yield | 13.02% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Concord Medical has an Altman Z-Score of 2.47 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.47 |
| Piotroski F-Score | 6 |